Medindia

X

ALung Hemolung Respiratory Dialysis System Receives FDA Expedited Access Pathway Designation

by Vishnuprasad on  November 7, 2015 at 6:54 PM Medical Gadgets   - G J E 4
ALung Technologies, a Pittsburgh, Pennsylvania firm, obtained Food and Drug Administration's (FDA) Expedited Access Pathway designation for its Hemolung Respiratory Assist System (RAS) that removes carbon dioxide from blood, letting the lungs rest without having to undergo ventilation.
ALung Hemolung Respiratory Dialysis System Receives FDA Expedited Access Pathway Designation
ALung Hemolung Respiratory Dialysis System Receives FDA Expedited Access Pathway Designation
Advertisement

Mechanical ventilation is a life saver for many critically ill patients. However, it requires sedation, intubation. The system can also lead to ventilator associated pneumonia and other complications.

‘ALung obtained Food and Drug Administration’s Expedited Access Pathway designation for its Hemolung Respiratory Assist System that eliminates carbon dioxide in the blood, letting the lungs rest without having to undergo ventilation.’
Advertisement
Expedited Access Pathway will permit to introduce life saving devices quicker, as long as they meet certain unmet needs.

ALung's technology was considered as one of the most interesting medical technology developments of 2010 and it's now coming to clinical use in the U.S

ALung Technologies' Hemolung wins appreciations by using dialysis to perform respiratory gas exchange in a process similar to extracorporeal membrane oxygenation.

During therapy, the patient can stay awake. In February 2010, the first patient was successfully treated with the device. The system could revolutionize the practice of medicine in the ICU.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All